Healio: Immunotherapy does not increase surgery complications for oral cavity cancer patients
Treating patients with advanced oral cavity cancer with an immunotherapy drug prior to surgery did not increase the risk for serious complications and was shown to potentially reduce poor surgical outcomes, according to new research presented at the American Head & Neck Society Annual Meeting led by University of Cincinnati researchers.
Researchers led by Alice L. Tang, MD, assistant clinical professor in the UC College of Medicine, reviewed the data of 32 patients enrolled in a clinical trial who received the immunotherapy drug pembrolizumab prior to surgery.
Complications are common after surgery to remove primary oral cavity cancer. However, the results showed no relevant differences in surgical outcomes between the control group and those who received the immunotherapy other than a statistically significant decrease in instances of lockjaw among those who received the immunotherapy.
“A lot of us have been suspicious that perhaps immunotherapy could cause poor wound healing, and this contradicts other data that have already been published,” Tang told Healio. “Surgeons in the community and clinicians should be reassured that there is emerging data that tells us more about adverse events after neoadjuvant immunotherapy, and that perhaps we’ll be OK with wound healing in this scenario.”
Tang said further study is needed with a larger sample size of patients to confirm findings.
“Neoadjuvant immunotherapy is going to be more and more important for head and neck cancers, particularly advanced disease,” Tang said. “We really need to know much more about the surgical implications and how this can affect outcomes.”
Featured photo at top of surgical tools in an operating room. Photo/University of Cincinnati.
Related Stories
Pocket-sized population threat
June 10, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
Cincinnati Children's LEND Program opens doors for UC graduate nursing students
June 9, 2026
UC graduate nursing students are broadening their expertise and career opportunities through the Cincinnati Children's LEND Program.
Patients with developmental disabilities may benefit with an integrated care model
June 9, 2026
Researchers from the University of Cincinnati and Ohio State University have found that adults with developmental disabilities who have integrated care were less likely to go to the emergency room or be hospitalized than others who were not. Their work was published in Disability and Health Journal.